Raptiva is once-a-week injection for treatment of psoriasis. It was pulled from the U.S. market on April 8, 2009. It was withdrawn because Raptiva suppresses the immune system, which increases the risk of serious infections, including a rare viral brain infection known as progressive multifocal leukoencephalopathy (PML). We are investigating cases of PML and other serious infections acquired by people when being treated with Raptiva. If you feel you have suffered as a result of Raptiva please reivew and fill out the below questionnaire. You may also call Maguire & […]
April 2009
If you feel you have been injured by Raptiva please consider and complete the questionnaire below. Please telephone, email or fax your answers to: Attorney Wayne Hassay Maguire & Schneider, LLP 250 Civic Center Drive, Ste 500 Columbus, OH 43215 phone: 614-224-1222 or 800-600-1222 fax: 614-224-1236 *protected email* Name: ________________________________________________ Address: ________________________________________________ ________________________________________________ E-mail Address:________________________________________________ Home Phone:______________________ Work Phone:____________________________ Social Security #:_______-_______-________ Date of Birth:______-_______-______ Date of Death (if applicable):___________________ Employer:________________________________ Job Title:____________________________ Employer Address: _______________________________________ _______________________________________ Number of Years Employed:___________________ Salary:_________________ Marital Status: Spouses Name:___________________________ Spouse’s Social Security #:______-____-_______ Date […]